65 related articles for article (PubMed ID: 21390706)
1. Retroviral vectors as insertional mutagens.
Gäken J; Farzaneh F
Methods Mol Biol; 1992; 8():111-30. PubMed ID: 21390706
[TBL] [Abstract][Full Text] [Related]
2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
3. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
4. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
[TBL] [Abstract][Full Text] [Related]
5. Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences.
Schübeler D; Maass K; Bode J
Biochemistry; 1998 Aug; 37(34):11907-14. PubMed ID: 9718314
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of retroviruses and oncogenes with the cellular genome. 1].
Scherdin U; Hölzel F
Arzneimittelforschung; 1987 Oct; 37(10):1205-9. PubMed ID: 2829931
[TBL] [Abstract][Full Text] [Related]
7. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.
Sokol M; Wabl M; Ruiz IR; Pedersen FS
Retrovirology; 2014 May; 11():36. PubMed ID: 24886479
[TBL] [Abstract][Full Text] [Related]
8. Bovine leukemia virus integration site selection in cattle that develop leukemia.
Murakami H; Yamada T; Suzuki M; Nakahara Y; Suzuki K; Sentsui H
Virus Res; 2011 Mar; 156(1-2):107-12. PubMed ID: 21237224
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
10. RTCGD: retroviral tagged cancer gene database.
Akagi K; Suzuki T; Stephens RM; Jenkins NA; Copeland NG
Nucleic Acids Res; 2004 Jan; 32(Database issue):D523-7. PubMed ID: 14681473
[TBL] [Abstract][Full Text] [Related]
11. Integration site selection by retroviruses.
Cereseto A; Giacca M
AIDS Rev; 2004; 6(1):13-21. PubMed ID: 15168737
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide sequence analysis of avian retroviruses: structural similarities with transposable elements.
Ju G; Hishinuma F; Skalka AM
Fed Proc; 1982 Aug; 41(10):2659-61. PubMed ID: 6286367
[TBL] [Abstract][Full Text] [Related]
13. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
[TBL] [Abstract][Full Text] [Related]
14. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
15. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
16. Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector.
Hong Y; Yu SS; Yoon NK; Kang SJ; Lee JT; Kim S; Kim JM; Lee K; Jang JW; Kim S
J Gene Med; 2008 Aug; 10(8):847-54. PubMed ID: 18563862
[TBL] [Abstract][Full Text] [Related]
17. Nakahara memorial lecture. Human T-cell leukemia virus type I: molecular biology and its implications in adult T-cell leukemia.
Yoshida M; Kiyokawa T; Watanabe T; Hattori S; Fujisawa J; Seiki M
Princess Takamatsu Symp; 1984; 15():39-47. PubMed ID: 6100651
[TBL] [Abstract][Full Text] [Related]
18. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.
Calomme C; Dekoninck A; Nizet S; Adam E; Nguyên TL; Van Den Broeke A; Willems L; Kettmann R; Burny A; Van Lint C
J Virol; 2004 Dec; 78(24):13848-64. PubMed ID: 15564493
[TBL] [Abstract][Full Text] [Related]
19. Activation of a MMTV/mdr3 fusion transcript from a cryptic viral promoter is stimulated by mdr-derived sequences located in intron I.
Lepage P; Underhill DA; Gros P
Virology; 1995 Jul; 210(2):244-53. PubMed ID: 7618265
[TBL] [Abstract][Full Text] [Related]
20. Integration of retroviral DNA into the genome of the infected cell.
Goff SP
Cancer Cells; 1990 Jun; 2(6):172-8. PubMed ID: 2201344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
